Seied Asadollah Mousavi Selected Research

Seied Asadollah Mousavi Research Topics

Disease

4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 01/2009
3	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 07/2014
3	COVID-19 01/2022 - 12/2020
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 11/2013 - 01/2009
2	Fanconi Anemia (Fanconi's Anemia) 01/2022 - 01/2009
2	Infections 01/2022 - 12/2021
2	beta-Thalassemia (Cooley's Anemia) 01/2021 - 01/2009
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2014 - 01/2009
1	Hemorrhagic Cystitis 10/2022
1	Pain (Aches) 10/2022
1	Stomatitis 10/2022
1	Hematologic Neoplasms (Hematological Malignancy) 01/2022
1	Neoplasms (Cancer) 01/2021
1	Leukemia 01/2021
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021
1	Sepsis (Septicemia) 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2019
1	Bronchiolitis Obliterans Syndrome 07/2014
1	Osteopetrosis 01/2009
1	Ovarian Neoplasms (Ovarian Cancer) 01/2009
1	Medulloblastoma 01/2009
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2009
1	Mucopolysaccharidosis I (Hurler Syndrome) 01/2009
1	Rhabdomyosarcoma 01/2009
1	Plasma Cell Leukemia 01/2009
1	Ewing Sarcoma (Sarcoma, Ewing) 01/2009
1	Systemic Scleroderma (Systemic Sclerosis) 01/2009
1	Infarction (Infarctions) 01/2009
1	Testicular Neoplasms (Testicular Cancer) 01/2009
1	Thalassemia 01/2009
1	Hodgkin Disease (Hodgkin's Disease) 01/2009
1	Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell) 01/2009
1	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 01/2009
1	Fibrosis (Cirrhosis) 01/2009
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2009
1	Chediak-Higashi Syndrome 01/2009
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2009
1	Breast Neoplasms (Breast Cancer) 01/2009
1	Sickle Cell Anemia (Hemoglobin S Disease) 01/2009
1	Pancreatoblastoma 01/2009
1	Aplastic Anemia (Anemia, Hypoplastic) 01/2009
1	Amyloidosis 01/2009
1	Nasopharyngeal Carcinoma 01/2009
1	Autosomal Recessive 3 Severe Congenital Neutropenia 01/2009
1	Multiple Myeloma 01/2009
1	Mucopolysaccharidoses 01/2009
1	Multiple Sclerosis 01/2009
1	Necrosis 01/2009
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2009
1	Wilms Tumor (Wilm's Tumor) 01/2009
1	Neuroblastoma 01/2009
1	Niemann-Pick Diseases (Niemann Pick Disease) 01/2009

Drug/Important Bio-Agent (IBA)

2	Imatinib Mesylate (Gleevec)FDA Link 11/2013 - 05/2013
2	Phosphotransferases (Kinase)IBA 11/2013 - 05/2013
1	Oral SpraysIBA 10/2022
1	Methotrexate (Mexate)FDA LinkGeneric 01/2022
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2022
1	VaccinesIBA 12/2021
1	Messenger RNA (mRNA)IBA 12/2021
1	COVID-19 VaccinesIBA 12/2021
1	Biomarkers (Surrogate Marker)IBA 10/2021
1	fibrin fragment D (D-dimer)IBA 12/2020
1	bcr-abl Fusion ProteinsIBA 11/2013
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 11/2013
1	Pharmaceutical PreparationsIBA 05/2013

Therapy/Procedure

4	Hematopoietic Stem Cell Transplantation 10/2022 - 01/2014
3	Transplantation 01/2022 - 01/2021
3	Therapeutics 01/2022 - 01/2009
3	Stem Cell Transplantation 07/2014 - 01/2009
2	Cell- and Tissue-Based Therapy (Cell Therapy) 10/2022 - 01/2021
1	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 01/2022
1	Remission Induction 01/2022
1	Drug Therapy (Chemotherapy) 01/2021
1	Adjuvant Chemotherapy 01/2019